Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cannon

Showing results (711-720 of 837) with videos related to

Pageof 84
Sort By:
The American Journal of Psychiatry|July 2, 2016
An Individualized Risk Calculator for Research in Prodromal PsychosisTyrone D Cannon, Changhong Yu, Jean Addington, et al.
Brain, Behavior, and Immunity|January 14, 2024
Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptomsColm Healy, Jonah Byrne, Subash Raj Suasi, et al.
Frontiers in Psychiatry|June 9, 2023
The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosisDaniel J Devoe, Lu Lui, Tyrone D Cannon, et al.
Schizophrenia Research|December 3, 2014
Stress exposure and sensitivity in the clinical high-risk syndrome: initial findings from the North American Prodrome Longitudinal Study (NAPLS)Hanan D Trotman, Carrie W Holtzman, Elaine F Walker, et al.
Schizophrenia Research|November 1, 2020
Depression: An actionable outcome for those at clinical high-riskJean Addington, Megan S Farris, Lu Liu, et al.
Neuroimage|October 27, 2004
Mapping cortical change in Alzheimer's disease, brain development, and schizophreniaPaul M Thompson, Kiralee M Hayashi, Elizabeth R Sowell, et al.
Schizophrenia Bulletin|October 17, 2017
Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential SubgroupsScott W Woods, Albert R Powers, Jerome H Taylor, et al.
Schizophrenia Bulletin|October 24, 2018
The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for PsychosisRicardo E Carrión, Andrea M Auther, Danielle McLaughlin, et al.
Molecular Neuropsychiatry|May 26, 2015
Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic DisordersYoonho Chung, Aron Jacobson, George He, et al.
Schizophrenia Bulletin|November 10, 2025
Neighborhood Characteristics and Social Functioning: Exploring Shared and Distinct Psychosocial Pathways Among Individuals at Clinical High-Risk for PsychosisQingyue E Yuan, Cope Feurer, Qing D Zhou, et al.
Pageof 84

Showing results (711-720 of 837) with videos related to

Sort By:
Pageof 84
The American Journal of Psychiatry|July 2, 2016
An Individualized Risk Calculator for Research in Prodromal PsychosisTyrone D Cannon, Changhong Yu, Jean Addington, et al.
Brain, Behavior, and Immunity|January 14, 2024
Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptomsColm Healy, Jonah Byrne, Subash Raj Suasi, et al.
Frontiers in Psychiatry|June 9, 2023
The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosisDaniel J Devoe, Lu Lui, Tyrone D Cannon, et al.
Schizophrenia Research|December 3, 2014
Stress exposure and sensitivity in the clinical high-risk syndrome: initial findings from the North American Prodrome Longitudinal Study (NAPLS)Hanan D Trotman, Carrie W Holtzman, Elaine F Walker, et al.
Schizophrenia Research|November 1, 2020
Depression: An actionable outcome for those at clinical high-riskJean Addington, Megan S Farris, Lu Liu, et al.
Neuroimage|October 27, 2004
Mapping cortical change in Alzheimer's disease, brain development, and schizophreniaPaul M Thompson, Kiralee M Hayashi, Elizabeth R Sowell, et al.
Schizophrenia Bulletin|October 17, 2017
Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential SubgroupsScott W Woods, Albert R Powers, Jerome H Taylor, et al.
Schizophrenia Bulletin|October 24, 2018
The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for PsychosisRicardo E Carrión, Andrea M Auther, Danielle McLaughlin, et al.
Molecular Neuropsychiatry|May 26, 2015
Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic DisordersYoonho Chung, Aron Jacobson, George He, et al.
Schizophrenia Bulletin|November 10, 2025
Neighborhood Characteristics and Social Functioning: Exploring Shared and Distinct Psychosocial Pathways Among Individuals at Clinical High-Risk for PsychosisQingyue E Yuan, Cope Feurer, Qing D Zhou, et al.
Pageof 84